How many insider declarations does bioAffinity Technologies, Inc. have?

bioAffinity Technologies, Inc. has filed 62 insider declarations with SEC (Form 4).

Who is the top reporting insider at bioAffinity Technologies, Inc.?

The top reporting insider at bioAffinity Technologies, Inc. is GIRGENTI STEVEN, based on the count of public filings.

What is the net insider buy vs sell volume on bioAffinity Technologies, Inc.?

Across the available history, declared buys total 0 and disposals 0.

InsiderTradesSIGMA

InsidersTradesSigma

← Companies ★ Sign in to follow

bioAffinity Technologies, Inc.: management transactions · United States · SEC (Form 4)

SEC:bioaffinity-technologies-inc-deccb6US·SEC (Form 4)

AMF

Browse the full insider trade history of bioAffinity Technologies, Inc., a listed issuer based in United States. Shares are listed on US US, under the supervision of SEC (Form 4). The latest transaction was disclosed on 14 January 2025 (Attribution). Among the most active insiders: GIRGENTI STEVEN. Every trade is free.

Insider Decl.

Thresholds

5 ops.

Buy Volume

0 ops.

Sell Volume

29Σ signal

Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.

Last declaration on 14 January 2025

Declarations62 total

◆

Zannes Maria

President & CEOExecutives10 Jan 2025

22SEC ↗

37,037 shares0Common StockSEC:0001493152-25-002150:0

◆

Reveles Xavier Trinidad

Chief Operating OfficerExecutives10 Jan 2025

bioAffinity Technologies, Inc.: management transactions · United States · SEC (Form 4)

Related companies and executives

bioAffinity Technologies, Inc.: management transactions · United States · SEC (Form 4)

Related companies and executives